3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
2
Esophageal Neoplasms
2
Breast Neoplasms
2
Anatomic Stage II Breast Cancer AJCC v8
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Salivary Gland Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Multiple Myeloma
1
Melanoma
1
Malignant Solid Neoplasm
1
Lymphoma
1
Hematologic Neoplasms
1
Glioma
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Anatomic Stage IV Breast Cancer AJCC v8
1
Anatomic Stage I Breast Cancer AJCC v8
1
Advanced Breast Carcinoma
1
Adenocarcinoma Of Esophagus
1
Interventions
pembrolizumab
45
Specimen Handling
45
Biopsy
37
Magnetic Resonance Spectroscopy
36
Paclitaxel
22
Nivolumab
21
Carboplatin
21
Gemcitabine
20
Radiosurgery
18
Irinotecan
16
Ipilimumab
13
Cisplatin
13
Capecitabine
12
130-nm albumin-bound paclitaxel
12
trastuzumab deruxtecan
11
Taxes
11
Pemetrexed
11
Cetuximab
11
olaparib
10
Leucovorin
10
Fluorouracil
10
Cyclophosphamide
10
durvalumab
9
Oxaliplatin
9
Bevacizumab
9
abemaciclib
8
X-Rays
8
Fulvestrant
8
Drug Therapy
8
palbociclib
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasm Metastasis
×
trastuzumab biosimilar HLX02
×
90 days
×
Clear all
No trials found.